Attachment 5 Sample Client Authorization Letter.docx

DOCX document 32 KB Posted

Attached to
Building 62 Renovation Federal contract opportunity
Solicitation number
75F40122R00086
Issued by
Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

About this file

This document contains a sample client authorization letter and information on a related federal contract opportunity for Building 62 Renovation at the U.S. Food and Drug Administration National Center for Toxicological Research facility in Jefferson, Arkansas. The letter is to be sent from an offering entity to its clients, requesting the clients complete a past performance evaluation questionnaire to be submitted directly to the FDA by October 14, 2022. The solicitation number for the renovation opportunity is 75F40122R00086. Past performance is a key factor in the source selection process. The renovation opportunity is being conducted by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services.

View the file

Other files for this federal contract opportunity

Other files attached to Building 62 Renovation, newest first.
File Type Posted
Amendment 5 Attachment 1 revised Sol Doc bldg 62 renovation.docx DOCX document
Amendment 5 Attachment 3 as-builts 1962 Pilot Line Facilities - 03-01-62.pdf PDF
Amendment 5.pdf PDF
Amendment 5 Attachment 2 Substitution Request form.pdf PDF
amendment 4.pdf PDF
amendment 3.pdf PDF
Amendment 3 Attachment 3 Section 280746-CAT 6.pdf PDF
Amendment 3 Attachment 1 Campus 1991-1992 - Street Lighting System - 11-24-92.pdf PDF
Amendment 3 Attachment 2 Table of Contents_10.03.2022.pdf PDF
Amendment 2 Attachment 2 updated Attachment J-3 Wage Decision.pdf PDF
Amendment 2 Attachment 3 09 6700-RESINOUS AGGREGATE FLOORING 09.30.2022.pdf PDF
Amendment 2 Attachment 1 revised Sol Doc bldg 62 renovation.pdf PDF
amendment 2.pdf PDF
Amendment 1 Attachment 3 Site Light cutsheet.pdf PDF
Amendment 1 Attachment 4 Adaptor cutsheet.pdf PDF
Amendment 1.pdf PDF
Amendment 1 Attachment 1 updated Specifications.pdf PDF
Amendment 1 Attachment 2 A1.02 22.09.12 UPDATE.pdf PDF
Attachment 2 D Drawings Bldg 62 Renovation.pdf PDF
Attachment 2 E Drawings Bldg 62 Renovation.pdf PDF
Attachment 2 G Drawings Bldg 62 Renovation.pdf PDF
Attachment 4 - Form FDA 3398.pdf PDF
Sol Doc 75F40122R00086 bldg 62 renovation.pdf PDF
Attachment 2 A Drawings Bldg 62 Renovation.pdf PDF
Attachment 2 B Drawings Bldg 62 Renovation.pdf PDF
Attachment 6 Past Performance Evaluation Questionnaire.docx DOCX document
Attachment 1 Project Manual Bldg 62 Renovation.pdf PDF
Attachment 2 C Drawings Bldg 62 Renovation.pdf PDF
Attachment 2 F Drawings Bldg 62 Renovation.pdf PDF
Attachment 3 Wage Determination.pdf PDF
Show all 30

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

75F40122R00086 ATTACHMENT J5

SAMPLE CLIENT AUTHORIZATION LETTER

(Transfer to Company Letterhead)

Dear Client, We are currently responding to Solicitation Number 75F40122R00086 for Building 62 Renovation at the U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), 3900 NCTR Road, Jefferson, Arkansas 72079.

The FDA has placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitations be identified and their participation in the evaluation process be requested; therefore, enclosed is a (present and) Past Performance Evaluation Questionnaire (PPEQ) for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration (FDA) no later than 1:00 pm central time on October 14, 2022 to Nick Sartain, Contract Specialist at nick.sartain@fda.hhs.gov.

If you have questions or require assistance regarding the attached questionnaire, please contact Nick Sartain, FDA Contract Specialist, at 870-543-7370 or at nick.sartain@fda.hhs.gov.

Thank you for your consideration and prompt response regarding this matter.

Sincerely, {Offering Entity}

File details come from the government source that posted it. Updated .